KURIYEL RALF
Known title: Senior VP, R&DCIK: 0001733143
Associated companies
Transaction History
| RGEN | ▲ Buy | Grant | 5,284 | $0 | 3/5/2026 | View on chart |
| RGEN | ▲ Buy | Grant | 125 | $0 | 3/4/2026 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 42 | $5K | 3/4/2026 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 923 | $115K | 3/2/2026 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 444 | $57K | 2/27/2026 | View on chart |
| RGEN | ▲ Buy | Grant | 4,826 | $0 | 3/3/2025 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 386 | $60K | 3/3/2025 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 391 | $61K | 2/27/2025 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 275 | $45K | 2/24/2025 | View on chart |
| RGEN | ▼ Sell | Open Market | 6,973 | $1.1M | 8/2/2024 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 175 | $15K | 8/2/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 175 | $28K | 8/2/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 4,465 | $740K | 8/1/2024 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 534 | $87K | 5/14/2024 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 1,271 | $109K | 3/11/2024 | View on chart |
| RGEN | ▼ Sell | Open Market | 3,517 | $681K | 3/11/2024 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 386 | $76K | 3/7/2024 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 135 | $26K | 3/4/2024 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 453 | $87K | 3/1/2024 | View on chart |
| RGEN | ▲ Buy | Grant | 404 | $0 | 2/29/2024 | View on chart |
| RGEN | ▲ Buy | Grant | 3,520 | $0 | 2/27/2024 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 710 | $109K | 5/16/2023 | View on chart |
| RGEN | ▲ Buy | Grant | 3,591 | $0 | 3/3/2023 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 1,247 | $234K | 3/3/2023 | View on chart |
| RGEN | ▲ Buy | Grant | 3,468 | $0 | 3/2/2023 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 358 | $62K | 2/28/2023 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 458 | $79K | 2/28/2023 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 2,000 | $66K | 8/11/2022 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 1,354 | $81K | 8/11/2022 | View on chart |
| RGEN | ▲ Buy | Option Exercise | 646 | $56K | 8/11/2022 | View on chart |
| RGEN | ▼ Sell | Open Market | 800 | $204K | 8/11/2022 | View on chart |
| RGEN | ▼ Sell | Open Market | 4,040 | $1.0M | 8/11/2022 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 712 | $107K | 5/13/2022 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 473 | $93K | 2/28/2022 | View on chart |
| RGEN | ▲ Buy | Grant | 4,234 | $0 | 2/28/2022 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 1,584 | $312K | 2/28/2022 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 477 | $94K | 2/27/2022 | View on chart |
| RGEN | ▲ Buy | Grant | 2,126 | $0 | 2/24/2022 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 188 | $36K | 2/24/2022 | View on chart |
| RGEN | ▲ Buy | Grant | 450 | $0 | 2/17/2022 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 175 | $32K | 2/17/2022 | View on chart |
| RGEN | ▼ Sell | Tax Withholding | 445 | $112K | 12/14/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Repligen Completes BioLife Solutions Acquisition
Repligen has finalized its acquisition of BioLife Solutions, a move that follows shareholder approval of the merger. This transaction expands Repligen's portfolio in the biopharmaceutical sector. The stock recently reached a 52-week high, reflecting market interest in the company's growth strategy.
Repligen Completes BioLife Solutions Acquisition. Repligen has finalized its acquisition of BioLife Solutions, a move that follows shareholder approval of the merger. This transaction expands Repligen's portfolio in the biopharmaceutical sector. The stock recently reached a 52-week high, reflecting market interest in the company's growth strategy.